| Mutation type:Point | Mutation effect:Missense | Nucleotide number:925 | |||
| Genome location:Exon9 | Subdomain:Serine protease | ||||
| Alpha missense prediction value:0.1348 | Alpha missense prediction class:benign | ||||
| No. of patients reported: 13 | |||||
| Patient information: Monoallelic variation (13); Biallelic variation (0) | |||||
| Patient | Sex | Age | Genotype | PC: amidolytic act (%) | PC: clotting act (%) | PC: Ag (%) | PCD type | Clinical presentation (age) | First onset age | Country | Comments | Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NA | NA | hetero | 55.8 | 54.5 | 53.4 | I | Other VTE | NA | France | NA | PMID: 32717757 |
| 2 | NA | NA | hetero | 55.8 | 54.5 | 53.4 | I | Other VTE | NA | France | NA | PMID: 32717757 |
| 3 | NA | NA | hetero | 55.8 | 54.5 | 53.4 | I | Other VTE | NA | France | NA | PMID: 32717757 |
| 4 | NA | NA | hetero | 55.8 | 54.5 | 53.4 | I | Other VTE | NA | France | NA | PMID: 32717757 |
| 5 | NA | NA | hetero | 55.8 | 54.5 | 53.4 | I | asymptomatic | NA | France | NA | PMID: 32717757 |
| 6 | NA | NA | hetero | 55.8 | 54.5 | 53.4 | I | asymptomatic | NA | France | NA | PMID: 32717757 |
| 7 | NA | NA | hetero | 55.8 | 54.5 | 53.4 | I | asymptomatic | NA | France | NA | PMID: 32717757 |
| 8 | NA | NA | hetero | 55.8 | 54.5 | 53.4 | I | asymptomatic | NA | France | NA | PMID: 32717757 |
| 9 | F | 33 | hetero | 55.5 | NA | 64.9 | I | miscarriage (n = 3) (20) | 20 | Poland | NA | PMID: 28607330 |
| 10 | F | 47 | hetero | 63 | NA | 69 | I | asymptomatic | 47 | Lebanon | FVL | PMID: 19535131 |
| 11 | M | 50 | hetero | 59 | NA | 58 | I | asymptomatic | 50 | Lebanon | NA | PMID: 19535131 |
| 12 | F | NA | hetero | 51 | NA | NA | I | Other VTE | NA | France | thrombosis (Other VTE) | PMID: 14707701 |
| 13 | M | NA | hetero | 45 | NA | NA | I | asymptomatic | NA | France | NA | PMID: 14707701 |
| Mutation type:Point | Mutation effect:Silent | Nucleotide number:927 | |||
| Genome location:Exon9 | Subdomain:Serine protease | ||||
| Alpha missense prediction value:— | Alpha missense prediction class:— | ||||
| No. of patients reported: 2 | |||||
| Patient information: Monoallelic variation (2); Biallelic variation (0) | |||||
| Patient | Sex | Age | Genotype | PC: amidolytic act (%) | PC: clotting act (%) | PC: Ag (%) | PCD type | Clinical presentation (age) | First onset age | Country | Comments | Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 63 | hetero | 38 | NA | NA | NA | stroke, ITP, dysarthria and OD (63), diabetes and immune thrombocytopenia (59) | 59 | Korea | Diplopia (OD) | PMID: 11456407 |
| 2 | M | 84 | hetero | 46 | NA | NA | NA | vertebrobasilar insufficiency, hypertension | 84 | Korea | NA | PMID: 11456407 |
| Mutation type:Point; Point | Mutation effect:Missense; Missense | Nucleotide number:925; 925 | |||
| Genome location:Exon9; Exon9 | Subdomain:Serine protease; Serine protease | ||||
| Alpha missense prediction value:0.1348; 0.1348 | Alpha missense prediction class:benign; benign | ||||
| No. of patients reported: 6 | |||||
| Patient information: Monoallelic variation (0); Biallelic variation (6) | |||||
| Patient | Sex | Age | Genotype | PC: amidolytic act (%) | PC: clotting act (%) | PC: Ag (%) | PCD type | Clinical presentation (age) | First onset age | Country | Comments | Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 21 | homo | 41 | NA | 34 | I | asymptomatic | 21 | Lebanon | FVL | PMID: 19535131 |
| 2 | F | 15 | homo | 41 | NA | 46 | I | asymptomatic | 15 | Lebanon | NA | PMID: 19535131 |
| 3 | M | 14 | homo | 33 | NA | 32 | I | asymptomatic | 14 | Lebanon | NA | PMID: 19535131 |
| 4 | F | 2 | homo | 3 | NA | 9 | I | asymptomatic | 2 | Lebanon | NA | PMID: 19535131 |
| 5 | F | 25 | homo | <1; 8 | NA | <1; 12 | I | DVT (16), DIC (18), Other VTE | 16 | Lebanon | thrombosis (Other VTE); intravenous streptokinase, unfractionated heparin, LMWH, anticoagulation therapy | PMID: 19535131 |
| 6 | NA | NA | homo | NA | 19 | 9 | I | DVT | 45 | France | NA | PMID: 7482420; PMID: 1347608 |
| Mutation type:Point; Point | Mutation effect:Missense; Missense | Nucleotide number:926; 926 | |||
| Genome location:Exon9; Exon9 | Subdomain:Serine protease; Serine protease | ||||
| Alpha missense prediction value:0.1007; 0.1007 | Alpha missense prediction class:benign; benign | ||||
| No. of patients reported: 1 | |||||
| Patient information: Monoallelic variation (0); Biallelic variation (1) | |||||
| Patient | Sex | Age | Genotype | PC: amidolytic act (%) | PC: clotting act (%) | PC: Ag (%) | PCD type | Clinical presentation (age) | First onset age | Country | Comments | Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 45 | homo | NA | 15 | NA | NA | Recurrent DVT, PE (15) | 15 | Japan | NA | PMID: 28111891 |
| Mutation type:Point; Point | Mutation effect:Silent; Silent | Nucleotide number:927; 927 | |||
| Genome location:Exon9; Exon9 | Subdomain:Serine protease; Serine protease | ||||
| Alpha missense prediction value:— | Alpha missense prediction class:— | ||||
| No. of patients reported: 1 | |||||
| Patient information: Monoallelic variation (0); Biallelic variation (1) | |||||
| Patient | Sex | Age | Genotype | PC: amidolytic act (%) | PC: clotting act (%) | PC: Ag (%) | PCD type | Clinical presentation (age) | First onset age | Country | Comments | Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 55 | homo | 50 | NA | NA | NA | end stage renal disease, Diabetes | 55 | Korea | NA | PMID: 11456407 |
| Mutation type:Point; Point | Mutation effect:Splice; Missense | Nucleotide number:-22; 926 | |||
| Genome location:Intron1; Exon9 | Subdomain:NA; Serine protease | ||||
| Alpha missense prediction value:0.1007 | Alpha missense prediction class:benign | ||||
| No. of patients reported: 1 | |||||
| Patient information: Monoallelic variation (0); Biallelic variation (1) | |||||
| Patient | Sex | Age | Genotype | PC: amidolytic act (%) | PC: clotting act (%) | PC: Ag (%) | PCD type | Clinical presentation (age) | First onset age | Country | Comments | Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NA | NA | c.hetero | NA | NA | NA | I | Other VTE | NA | France | thrombosis (Other VTE) | PMID: 10669160 |
| Mutation type:Point; Point | Mutation effect:Missense; Missense | Nucleotide number:541; 926 | |||
| Genome location:Exon7; Exon9 | Subdomain:Linker; Serine protease | ||||
| Alpha missense prediction value:0.4146; 0.1007 | Alpha missense prediction class:ambiguous; benign | ||||
| No. of patients reported: 1 | |||||
| Patient information: Monoallelic variation (0); Biallelic variation (1) | |||||
| Patient | Sex | Age | Genotype | PC: amidolytic act (%) | PC: clotting act (%) | PC: Ag (%) | PCD type | Clinical presentation (age) | First onset age | Country | Comments | Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 12 | c.hetero | NA | 27 | 21 | I | Epilepsy (3), Other VTE (12) | 3 | Japan | thrombosis (Other VTE) | PMID: 28111891 |
| Mutation type:Point; Point | Mutation effect:Missense; Missense | Nucleotide number:793; 925 | |||
| Genome location:Exon8; Exon9 | Subdomain:Serine protease; Serine protease | ||||
| Alpha missense prediction value:0.3365; 0.1348 | Alpha missense prediction class:benign; benign | ||||
| No. of patients reported: 1 | |||||
| Patient information: Monoallelic variation (0); Biallelic variation (1) | |||||
| Patient | Sex | Age | Genotype | PC: amidolytic act (%) | PC: clotting act (%) | PC: Ag (%) | PCD type | Clinical presentation (age) | First onset age | Country | Comments | Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 12 | c.hetero | 6 | 6 | 6 | I | multiple DVT (12), Other VTE | 12 | France | thrombosis (Other VTE); LMWH, Fraxiparin | PMID: 14707701 |